Navigation Links
Prioritizing lab testing for patients on antiretroviral treatment in resource-constrained settings
Date:4/18/2012

In this week's PLoS Medicine, Luis Montaner from the Wistar Institute, Philadelphia, USA and colleagues retrospectively apply a potential capacity-saving CD4 count model to a cohort of HIV-infected patients on antiretroviral therapy. The study's findings suggest that the model could be used to optimize laboratory capacity in settings where resources are limited. The authors stress that the method is not intended to replace CD4 count testing or establish a second tier of healthcare, rather the model is intended as a triage tool to prioritize laboratory capacity for patients who are a high priority.

The authors state: "the implementation of our method could help focus laboratory-based CD4 count testing capacity on patients with higher likelihood of CD4 failure. This work provides the basis for future prospective testing of the model's overall safety, cost effectiveness and clinical outcomes in low-resource settings."


'/>"/>
Contact: Katie Hickling
press@plos.org
Public Library of Science
Source:Eurekalert

Page: 1

Related biology technology :

1. Arsenic Testing Proves Organic Baby Formula Safe
2. Premier Research Expands Salt Lake City and Phoenix Testing Facilities Adding 50% Capacity
3. HPV Testing for Cervical Cancer Risk Patients set to Increase
4. India In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture
5. Sigma-Aldrich to Acquire BioReliance; Extending Its Reach into Biopharmaceutical Testing and Services
6. LABS, Inc. Earns AABB Accreditation for Donor Testing
7. Members of Congress, Cancer Experts Address Impact of Genetic Testing on Cancer
8. VetNostic Laboratories® Announces New Testing for Dog Breeds
9. US Microbiology Testing Market
10. HABIT Study Highlights Home BNP Testing May Allow for Earlier Interventions and Better Management of Heart Failure Patient
11. New White Paper Examines Clinical Trial Material Production & Testing: What Your Contract Manufacturing Organization is Not Telling You
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... Spain , Dec. 8, 2016  Anaconda BioMed ... the development of the next generation neuro-thrombectomy system for ... appointment of Tudor G. Jovin, MD to join its ... serve as a strategic network of scientific and clinical ... the development of the ANCD BRAIN ® to ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... launch of flexible packaging for their exceptionally efficient human mesenchymal stem/stromal cell ... RoosterBio’s portfolio of bioprocess media products engineered to radically streamline culture processes, ...
(Date:12/8/2016)... , ... December 08, 2016 , ... This CAST literature ... for biotech crops. The authors focus on the economic effects in countries that are ... of new biotech crops and the resultant risk of low level presence (LLP) puts ...
(Date:12/8/2016)... , Dec. 8, 2016 Soligenix, Inc. ... company focused on developing and commercializing products to treat ... announced today that it will be hosting an Investor ... ET on the origins of innate defense regulators (IDRs) ... review of oral mucositis and the recently announced and ...
Breaking Biology Technology:
(Date:11/17/2016)... CITY OF INDUSTRY, Calif. , Nov. 17, 2016  AIC announces that it ... about using NVMe storage servers in organizations that require high-performance scale-out plus high speed data transfer ... ... ... Setting ...
(Date:11/15/2016)... 15, 2016  Synthetic Biologics, Inc. (NYSE MKT: ... on the gut microbiome, today announced the pricing ... of its common stock and warrants to purchase ... price to the public of $1.00 per share ... from the offering, excluding the proceeds, if any ...
(Date:11/14/2016)... SARASOTA, Fla., Nov. 14, 2016  xG Technology, Inc. ... in providing critical wireless communications for use in challenging ... ended September 30, 2016. Management will hold a conference ... at 5:00 p.m. Eastern Time (details below). ... announced a $16 million binding agreement to acquire Vislink ...
Breaking Biology News(10 mins):